Developing new antibiotics – essential research should not be a question of money
Why has the pharma industry and its talents lost interest in developing new antibiotics?
List view / Grid view
Why has the pharma industry and its talents lost interest in developing new antibiotics?
Research has found that North America had the most strategic partnerships in the pharma industry from 2014 to 2019.
Despite plans to lower drug prices in the US, political divisions have muddied the waters. This article examines the efforts made by those involved and the possibilities of their success.
The global pharma contract development and manufacturing organisation (CDMO) outsourcing market is predicted to grow.
CPhI Worldwide now comprises six individual pharma events and more than 20 dedicated zones.
When it comes to quality control for liquid drug manufacturers, it’s important to meet regulations while minimizing waste.
Research has found that the pharmaceutical industry in India must encourage innovation in order to keep up with the growth of the sector.
An event was held last week, exploring the manufacturing and potential of cannabinoids within the pharmaceutical industry.
A treatment for anaemia associated with chronic kidney disease in dialysis patients has been approved in Japan.
Darmerica LLC is voluntarily recalling two lots of quinacrine dihydrochloride due to a label mix-up.
The UK Medicine and Healthcare products Regulatory Agency has released a revision to its standards for ensuring high quality of biologic products.
The market for containment facilities and containment manufacturing will increase in the future, due to a growing demand for oncology treatments.
The EMA has announced it is drafting guidance on how to avoid the presence of nitrosamines, a probable carcinogenic ingredient, in drugs.
CPhI Worldwide will return for its 30th year on 5-7 November 2019 at Messe Frankfurt in Frankfurt, Germany.
Both the intravenous and oral formulations of the antifungal candidate, fosmanogepix, have been granted Fast Track designation by the FDA.